Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Novartis
Express Scripts
Cerilliant
Colorcon
Cipla
Baxter
Dow
Federal Trade Commission
Moodys
US Army

Generated: February 23, 2018

DrugPatentWatch Database Preview

PREDNISOLONE SODIUM PHOSPHATE - Generic Drug Details

« Back to Dashboard

What are the generic drug sources for prednisolone sodium phosphate and what is the scope of prednisolone sodium phosphate patent protection?

Prednisolone sodium phosphate
is the generic ingredient in thirteen branded drugs marketed by Merck, Watson Labs, Novartis, Schering, Pharmafair, Akorn, Alcon Pharms Ltd, Bausch And Lomb, Sola Barnes Hind, Concordia Pharms Inc, Seton Pharm, Amneal Pharms, Chartwell Rx, Edenbridge Pharms, Hi Tech Pharma, Medicis Pharms, Mission Pharma, Nesher Pharms, Pharm Assoc, Vintage, Vintage Pharms, We Pharms, Wockhardt Bio Ag, Mylan Pharms Inc, and Sandoz Inc, and is included in forty-one NDAs. There is one patent protecting this compound and one Paragraph IV challenge. Additional information is available in the individual branded drug profile pages.

Prednisolone sodium phosphate has nine patent family members in seven countries.

There are eighty-six drug master file entries for prednisolone sodium phosphate. Twenty-three suppliers are listed for this compound.
Summary for PREDNISOLONE SODIUM PHOSPHATE
Pharmacology for PREDNISOLONE SODIUM PHOSPHATE

US Patents and Regulatory Information for PREDNISOLONE SODIUM PHOSPHATE

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Pharm Assoc PREDNISOLONE SODIUM PHOSPHATE prednisolone sodium phosphate SOLUTION;ORAL 078465-001 Mar 7, 2008 AA RX No Yes ➤ Sign Up ➤ Sign Up ➤ Sign Up
Novartis INFLAMASE MILD prednisolone sodium phosphate SOLUTION/DROPS;OPHTHALMIC 080751-001 Approved Prior to Jan 1, 1982 DISCN No No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Bausch And Lomb SULFACETAMIDE SODIUM AND PREDNISOLONE SODIUM PHOSPHATE prednisolone sodium phosphate; sulfacetamide sodium SOLUTION/DROPS;OPHTHALMIC 074449-001 Dec 29, 1995 AT RX No Yes ➤ Sign Up ➤ Sign Up ➤ Sign Up
Nesher Pharms PREDNISOLONE SODIUM PHOSPHATE prednisolone sodium phosphate SOLUTION;ORAL 076988-001 May 24, 2005 DISCN No No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Mylan Pharms Inc PREDNISOLONE SODIUM PHOSPHATE prednisolone sodium phosphate TABLET, ORALLY DISINTEGRATING;ORAL 202179-002 Apr 10, 2013 AB RX No No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Concordia Pharms Inc ORAPRED ODT prednisolone sodium phosphate TABLET, ORALLY DISINTEGRATING;ORAL 021959-001 Jun 1, 2006 AB RX Yes No ➤ Sign Up ➤ Sign Up Y ➤ Sign Up
Novartis VASOCIDIN prednisolone sodium phosphate; sulfacetamide sodium SOLUTION/DROPS;OPHTHALMIC 018988-001 Aug 26, 1988 DISCN Yes No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Akorn SULSTER prednisolone sodium phosphate; sulfacetamide sodium SOLUTION/DROPS;OPHTHALMIC 074511-001 Jul 30, 1996 DISCN No No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Amneal Pharms PREDNISOLONE SODIUM PHOSPHATE prednisolone sodium phosphate SOLUTION;ORAL 078345-001 Mar 10, 2009 DISCN No No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Sola Barnes Hind PREDNISOLONE SODIUM PHOSPHATE prednisolone sodium phosphate SOLUTION/DROPS;OPHTHALMIC 084168-001 Approved Prior to Jan 1, 1982 DISCN No No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

Expired US Patents for PREDNISOLONE SODIUM PHOSPHATE

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Seton Pharm PEDIAPRED prednisolone sodium phosphate SOLUTION;ORAL 019157-001 May 28, 1986 ➤ Sign Up ➤ Sign Up
Concordia Pharms Inc ORAPRED ODT prednisolone sodium phosphate TABLET, ORALLY DISINTEGRATING;ORAL 021959-003 Jun 1, 2006 ➤ Sign Up ➤ Sign Up
Concordia Pharms Inc ORAPRED ODT prednisolone sodium phosphate TABLET, ORALLY DISINTEGRATING;ORAL 021959-001 Jun 1, 2006 ➤ Sign Up ➤ Sign Up
Concordia Pharms Inc ORAPRED ODT prednisolone sodium phosphate TABLET, ORALLY DISINTEGRATING;ORAL 021959-002 Jun 1, 2006 ➤ Sign Up ➤ Sign Up
Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

International Patents for PREDNISOLONE SODIUM PHOSPHATE

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

US Department of Justice
Daiichi Sankyo
Express Scripts
US Army
Covington
Harvard Business School
Accenture
Colorcon
UBS

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

botpot